The efficacy and safety of risperidone for the treatment of geriatric psychosis

Journal of Clinical Psychopharmacology

Volumn 21, Issue 6, 2001, Pages 583-587

  Hwang, Jen Ping ^a,b   Yang, Cheng Hung ^a,b   Yu, Hsieh Chiao ^c   Chang, Jay Wen ^d   Cheng, Chih Ya ^a   Tsai, Shih Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Chia Nan Psychiatric Center   (Taiwan)

^d Yuanshan Veterans Hospital   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GAIT DISORDER; GERIATRIC DISORDER; GERONTOPSYCHIATRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; PSYCHOSIS; TAIWAN; VERTIGO;

AGED; AGED, 80 AND OVER; AGING; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; RISPERIDONE; TREATMENT OUTCOME;

EID: 0035199185     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200112000-00007     Document Type: Article

References (21)

1. Psychoses in the elderly: A spectrum of disorders
2. A study of antipsychotic drug use in nursing homes: Epidemiologic evidence suggesting misuse
3. Risperidone in the treatment of affective illness and obsessive-compulsive disorder
4. Psychosis in medical conditions: Response to risperidone
5. Use of risperidone in delirium: Case reports
6. Risperidone in the treatment of mania
7. The Brief Psychiatric Rating Scale
8. Sandoz Clinical Assessment-Geriatric (SCAG)
9. ECDEU assessment manual for psychopharmacology
10. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial
11. Risperidone in the elderly: A pharmacoepidemiologic study
12. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
13. Risperidone in the treatment of negative symptoms of schizophrenia: A meta-analysis
14. Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
15. Outcome of risperidone therapy in elderly patients with chronic psychosis
16. Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man
17. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder
18. Efficacy of antipsychotics in the treatment of the behavioral complications of dementia: A review of the literature
19. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up
20. Edema associated with addition of risperidone to valproate treatment